Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Optimalization of Nephroprotection Using N-Acetylcysteine
This study has been completed.
Study NCT00572663 Information provided by Medical University of Gdansk
First Received: December 12, 2007 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Proteinuria
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Failure
Renal Insufficiency
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
ACC (N-acetylcysteine) 1200 mg
Additional drug interventions recognized in this trial
Acetylcysteine
N-monoacetylcystine
More general drug interventions related to this trial
Anti-Infective Agents
Antidotes
Antioxidants
Antiviral Agents
Expectorants
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Medical University of Gdansk
Back to top of Main Content
